Other

Roche to pay $7.1 bn for Telavant Holdings

Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.

Diseases, Conditions, Syndromes

Roche develops monkeypox PCR tests

Swiss pharmaceutical giant Roche said Wednesday it had come up with PCR tests that can detect monkeypox, as the virus spreads outside endemic countries.

Diseases, Conditions, Syndromes

Roche launches test for coronavirus variants

Swiss pharma giant Roche announced Tuesday the launch of a new test to help researchers find coronavirus variants which are feared to be more harmful or could undermine vaccines.

Diseases, Conditions, Syndromes

Roche teams up with Atea in US on oral coronavirus treatment

Swiss pharmaceuticals giant Roche said Thursday it is collaborating with Atea Pharmaceuticals on the development of an orally administered drug to treat coronavirus patients who have not been hospitalised.

page 1 from 7